Looks to me they may be working on a partnership with big pharma or bio. Our CEO is top notch with a PhD in chemistry and an MBA in business. I dare say he knows what he is doing. And I'm quite confident that our drug will show significant improvement over Aricept alone. As I understand it, the trial includes people already on Aricept, so there is a base line for Aricept alone. Now they are continuing to take Aricept along with Anavex 2-73. I don't lose any sleep over this investment. The company seems unusually quite so that leads me to believe something is in the works. One of our ceo's goals is to get Anavex on NASDAQ this year. He gets a one million share bonus when he does.